Healthequity Stock Analysis

HQY -  USA Stock  

USD 62.80  1.82  2.98%

The current bullish price patterns experienced by current Healthequity shareholders may raise some interest from investors. The stock closed today at a share price of 62.80 on 412,800 in trading volume. The company directors and management have been very successful in rebalancing the firm assets at opportune times to take advantage of market volatility in April. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.48. The current volatility is consistent with the ongoing market swings in April 2022 as well as with Healthequity unsystematic, company-specific events.
Please check Risk vs Return Analysis.
  
Refresh
The Healthequity stock analysis report makes it easy to digest most publicly released information about Healthequity and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Healthequity Stock analysis module also helps to analyze the Healthequity price relationship with some important fundamental indicators such as market cap and management efficiency.

Healthequity Stock Analysis Notes

About 102.0% of the company shares are owned by institutional investors. The book value of Healthequity was currently reported as 22.39. The company has Price/Earnings (P/E) ratio of 789.3. Healthequity recorded a loss per share of 0.08. The entity had not issued any dividends in recent years. HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people. To learn more about Healthequity call Jon Kessler at 801 727 1000 or check out https://www.healthequity.com.

Healthequity Quarterly Cost of Revenue

98 Million

Share

Healthequity Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Healthequity's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Healthequity or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
The company reported the last year's revenue of 756.56 M. Reported Net Loss for the year was (44.29 M) with profit before taxes, overhead, and interest of 423.71 M.
Latest headline from simplywall.st: These 4 Measures Indicate That HealthEquity Is Using Debt Extensively - Simply Wall St

Healthequity Upcoming and Recent Events

Earnings reports are used by Healthequity to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Healthequity previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report21st of March 2022
Next Financial Report6th of June 2022
Next Fiscal Quarter End31st of January 2022
Next Fiscal Year End21st of March 2022
Last Quarter Report31st of October 2021
Last Financial Announcement31st of January 2021

Healthequity Largest EPS Surprises

Earnings surprises can significantly impact Healthequity's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-12-07
2015-10-310.070.080.0114 
2015-09-08
2015-07-310.080.090.0112 
2015-06-08
2015-04-300.090.10.0111 
View All Earnings Estimates

Healthequity SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Healthequity prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Healthequity investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Healthequity specific information freely available to individual and institutional investors to make a timely investment decision.
16th of May 2022
Financial Statements and Exhibits. Regulation FD Disclosure
View
2nd of May 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
22nd of March 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
22nd of February 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
11th of February 2022
Unclassified Corporate Event
View
10th of February 2022
Unclassified Corporate Event
View
7th of February 2022
Unclassified Corporate Event
View
10th of January 2022
Financial Statements and Exhibits. Regulation FD Disclosure
View

Healthequity Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Healthequity is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Healthequity backward and forwards among themselves. Healthequity's institutional investor refers to the entity that pools money to purchase Healthequity's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Blackrock IncCommon Shares9.4 M635.5 M
Vanguard Group IncCommon SharesM539.4 M
Wasatch Advisors IncCommon Shares7.6 M515.2 M
Fmr LlcCommon Shares3.2 M216.9 M
William Blair Investment Management LlcCommon Shares3.1 M209.9 M
Jpmorgan Chase CoCommon Shares2.7 M180 M
State Street CorpCommon Shares2.6 M178.2 M
Note, although Healthequity's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Healthequity Market Capitalization

The company currently falls under 'Mid-Cap' category with total capitalization of 4.95 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Healthequity's market, we take the total number of its shares issued and multiply it by Healthequity's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Healthequity Profitablity

Healthequity's profitability indicators refer to fundamental financial ratios that showcase Healthequity's ability to generate income relative to its revenue or operating costs. If, let's say, Healthequity is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Healthequity's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Healthequity's profitability requires more research than a typical breakdown of Healthequity's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (5.85) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 5.36 %, which entails that for every 100 dollars of revenue, it generated 0.05 of operating income.
Last ReportedProjected for 2022
Return on Investment 1.69  1.74 
Return on Average Assets(0.014) (0.0144) 
Return on Average Equity(0.024) (0.0246) 
Return on Invested Capital(0.026) (0.0267) 
Return on Sales(0.04) (0.0411) 

Management Efficiency

The entity has Return on Asset of 0.87 % which means that on every $100 spent on asset, it made $0.87 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (2.74) %, meaning that it generated no profit with money invested by stockholders. Healthequity management efficiency ratios could be used to measure how well healthequity manages its routine affairs as well as how well it operates its assets and liabilities. Return on Investment is likely to rise to 1.74 in 2022, whereas Return on Average Assets are likely to drop (0.0144)  in 2022. Healthequity Total Assets are fairly stable at the moment as compared to the past year. Healthequity reported Total Assets of 3.11 Billion in 2021. Assets Non Current is likely to rise to about 3 B in 2022, whereas Current Assets are likely to drop slightly above 316.7 M in 2022.
Last ReportedProjected for 2022
Book Value per Share 22.28  24.04 
Enterprise Value over EBIT(160.00) (164.21) 
Enterprise Value over EBITDA 45.12  48.80 
Price to Book Value 2.41  2.47 
Tangible Assets Book Value per Share 5.87  6.03 
Enterprise Value4.8 B4.7 B
Tangible Asset Value488.1 M418.3 M

Technical Drivers

As of the 28th of May, Healthequity retains the market risk adjusted performance of 0.2294, and Risk Adjusted Performance of 0.1579. Healthequity technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to break down and collect data for nineteen technical drivers for Healthequity, which can be compared to its competitors. Please check out Healthequity standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Healthequity is priced fairly, providing market reflects its last-minute price of 62.8 per share. Given that Healthequity has jensen alpha of 0.2671, we strongly advise you to confirm Healthequity's regular market performance to make sure the company can sustain itself at a future point.

Healthequity Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.
.

Healthequity Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Healthequity insiders, such as employees or executives, is commonly permitted as long as it does not rely on Healthequity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Healthequity insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Healthequity Predictive Daily Indicators

Healthequity intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Healthequity stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Healthequity Forecast Models

Healthequity time-series forecasting models is one of many Healthequity's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Healthequity's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Healthequity Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Healthequity stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Healthequity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Healthequity. By using and applying Healthequity Stock analysis, traders can create a robust methodology for identifying Healthequity entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin 5.33  5.47 
EBITDA Margin 0.14  0.21 
Gross Margin 0.56  0.63 
Profit Margin(0.06) (0.06) 
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.

Current Healthequity Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Healthequity analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Healthequity analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
64.8Buy10Odds
Healthequity current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Healthequity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Healthequity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Healthequity, talking to its executives and customers, or listening to Healthequity conference calls.
Healthequity Analyst Advice Details

Healthequity Stock Analysis Indicators

Healthequity stock analysis indicators help investors evaluate how Healthequity stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Healthequity shares will generate the highest return on investment. By understating and applying Healthequity stock analysis, traders can identify Healthequity position entry and exit signals to maximize returns.
Quick Ratio2.04
Fifty Two Week Low36.81
Revenue Growth8.00%
Shares Short Prior Month4.3M
Average Daily Volume Last 10 Day658.12k
Average Daily Volume In Three Month706.39k
Shares Percent Shares Out4.94%
Gross Margins56.01%
Short Percent Of Float5.64%
Forward Price Earnings36.34
Float Shares82.16M
Fifty Two Week High84.78
Enterprise Value To Ebitda33.79
Fifty Day Average62.63
Two Hundred Day Average59.24
Enterprise Value To Revenue7.94
Please check Risk vs Return Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.